États-Unis · Agences & temps réel · Business Wire

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

Publié par Business Wire · États-Unis il y a 14 h

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its ...

Lire l'article complet sur Business Wire Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.businesswire.com)

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

À lire aussi

LAZ and indiGOtech Form Joint Venture to Bring Sustainable EV Charging to More Apartments and Condos

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

Partager

À lire aussi

LAZ and indiGOtech Form Joint Venture to Bring Sustainable EV Charging to More Apartments and Condos

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening